Statistics
Publications
13
Citations
491
H-Index
11
Active since
1988
H. Roché is an author at Institut Claudius Regaud specializing in medicine, oncology, and pharmacology.
Publications per year
1988–2016
13
13
Phase II trial of dasatinib in triple-negative breast cancer: results of study CA180059.
RS Finn, Carmelo Bengala, Nuhad Ibrahim et al. · Cancer Research · 2009 · 70 citations
Medicine, Oncology, Pharmacology +17
José Baselga, H. Roché, F. Costa et al. · Cancer Research · 2009 · 52 citations
Medicine, Oncology, Pharmacology +15
Clinical pharmacodynamic factors in docetaxel toxicity
Florent Puisset, J. Alexandre, Valérie Raoul et al. · British Journal of Cancer · 2007 · 42 citations · Full text
1–5 of 13